The Latest Updates in Longevity Research with Dr. Eric Verdin
Publisher |
InsideTracker
Media Type |
audio
Categories Via RSS |
Health & Fitness
Nutrition
Science
Publication Date |
Dec 13, 2023
Episode Duration |
01:06:04

This episode of Longevity by Design features an interview with Dr. Eric Verdin—the CEO of The Buck Institute. The Buck Institute was the first center dedicated to aging research, and many discoveries within the aging field have come out of this research center. 

For this episode, Dr. Verdin, Dr. Blander, and Ashely Reaver sat down in person to discuss the latest updates in longevity research. Dr. Verdin shares his opinion on questions like “is aging a disease?” and “is there a maximum lifespan that humans will never surpass?” Dr. Verdin also discusses updates on the future of anti-aging drugs, including senolytics and metformin. 

To close the episode, Dr. Verdin gives life advice for what 5 things we can do on a regular basis to improve our health span.

Listen to all episodes of Longevity by Design at https://info.insidetracker.com/longevitybydesign Episode timestamps: 

  • Introduction: (0:00–2:40) 
  • About the Buck Institute (2:40–8:00)
  • Biological aging clocks (8:00–14:31)
  • Public opinion and funding aging research (14:31–16:38) 
  • Is aging a disease? (16:38–19:35) 
  • Future of anti-aging drugs (19:35–25:25) 
  • Senescence and senolytics (25:25–29:42) 
  • The hallmarks of aging are interconnected (29:42–36:48) 
  • How medicine and public policy has improved life expectancy (36:48–40:50) 
  • How much of longevity is due to genetics? (40:50–44:52) 
  • Geographic location impacts life expectancy (44:52–51:08) 
  • Is there a maximum lifespan for humans? (51:08–56:40) 
  • Healthspan vs lifespan (56:40–60:04) 
  • The most important interventions to improve healthspan (60:04–1:06:04)  

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review